6 result(s) have been found!
| Accession | Name | Sequence | Source/Organism | Mechanism | Assay Type | Cell Line | Cancer Type | Activity |
|---|---|---|---|---|---|---|---|---|
| dbacp07937 | Pantinin-1 | GILGKLWEGFKSIV | Synthetic | Selective binding, membrane disruption, apoptosis | MTS assay | MDA-MB-231 | Breast Cancer | IC50 = 28.5 ± 1.0 µM |
| dbacp07938 | Pantinin-1 | GILGKLWEGFKSIV | Synthetic | Selective binding, membrane disruption, apoptosis | MTS assay | DU-145 | Prostate Cancer | IC50 = 47.5 ± 2.0 µM |
| dbacp07939 | Pantinin-2 | IFGAIWKGISSLL | Synthetic | Selective binding, membrane disruption, apoptosis | MTS assay | MDA-MB-231 | Breast Cancer | IC50 = 12.5 ± 1.0 µM |
| dbacp07940 | Pantinin-2 | IFGAIWKGISSLL | Synthetic | Selective binding, membrane disruption, apoptosis | MTS assay | DU-145 | Prostate Cancer | IC50 = 16.5 ± 1.0 µM |
| dbacp07941 | Pantinin-3 | FLSTIWNGIKSLL | Synthetic | Selective binding, membrane disruption, apoptosis | MTS assay | MDA-MB-231 | Breast Cancer | IC50 = 13.5 ± 2.0 µM |
| dbacp07942 | Pantinin-3 | FLSTIWNGIKSLL | Synthetic | Selective binding, membrane disruption, apoptosis | MTS assay | DU-145 | Prostate Cancer | IC50 = 17.3 ± 1.0 µM |